Optimizing Heparin and Protamine Dosing During Cardiopulmonary Bypass Using Activated Clotting Time-Guided Protocols: A Single-Centre Prospective Randomized Controlled Trial
Interdisciplinary CardioVascular and Thoracic Surgery · 2026
DOI: 10.1093/icvts/ivag197 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2026. Verfasst von Youssef El Dsouki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Maastricht University Medical Centre MUMC, Maastricht 6229 HX, The Netherlands. Hauptthemen laut MEDLINE: Protamines, Heparin, Cardiopulmonary Bypass, Coronary Artery Bypass. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To evaluate whether an activated clotting time (ACT)-guided, formula-based anticoagulation strategy supported by viscoelastic coagulation monitoring (ROTEM) improves perioperative coagulation management and reduces bleeding compared with standard weight-based heparin dosing in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB).
Methods
In this single-centre prospective, randomized controlled trial, 100 adults undergoing isolated CABG with CPB were allocated to ACT-guided management (n = 50) or standard care (n = 50). The ACT-guided group received individualized heparin and protamine dosing calculated using predefined ACT-based formulas targeting ACT ≥400 seconds. The control group received a fixed heparin bolus (300 IU/kg) with empirical protamine reversal. ROTEM was performed preoperatively, intraoperatively, and postoperatively. The primary end-point was total chest drain output at 24 hours. Secondary end-points included transfusion requirements, thrombotic events, platelet count variation, oxygenator performance, additional heparin or protamine use, ROTEM-derived parameters, and perioperative clinical outcomes.
Results
The ACT-guided group had lower 24-hour chest drain bleeding and reduced total exposure to heparin and protamine. Intraoperative ACT values were more consistently within target range, with fewer supplemental heparin doses required. ROTEM demonstrated shorter clotting times and improved clot firmness, indicating reduced postoperative hypocoagulability. Platelet decline during CPB was attenuated. Transfusion rates (28% vs 52%, P = .01) and total allogeneic units transfused (0.6 ± 1.0 vs 1.4 ± 1.6, P = .003) were significantly lower, with no observed increase in thrombotic events.
Conclusions
Activated clotting time-guided, formula-based anticoagulation supported by ROTEM was associated with more favourable coagulation parameters and reduced bleeding without evidence of increased thrombotic complications within the limitations of the study sample size. Larger prospective studies are warranted to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Maastricht University Medical Centre MUMC, Maastricht 6229 HX, The Netherlands.
- Cardiovascular Research Centre Maastricht CARIM, Maastricht 6229 ER, The Netherlands.
- School of Medicine and Surgery, University of Insubria, Varese 21100, Italy.
- Department of Cardiovascular Surgery, Medical Park Hospital, YIH University, Ankara 06680, Turkey.
ORCID-Profile: Youssef El Dsouki, Ignazio Condello, Roberto Lorusso
Zitieren
APA
El Dsouki, Y., Condello, I., Gunertem, O. E., Yildirim, A., Gunaydin, S., & Lorusso, R. (2026). Optimizing Heparin and Protamine Dosing During Cardiopulmonary Bypass Using Activated Clotting Time-Guided Protocols: A Single-Centre Prospective Randomized Controlled Trial. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivag197
Vancouver
El Dsouki Y, Condello I, Gunertem OE, Yildirim A, Gunaydin S, Lorusso R. Optimizing Heparin and Protamine Dosing During Cardiopulmonary Bypass Using Activated Clotting Time-Guided Protocols: A Single-Centre Prospective Randomized Controlled Trial. Interdisciplinary CardioVascular and Thoracic Surgery. 2026. doi:10.1093/icvts/ivag197
BibTeX
@article{ElDsouki2026,
author = {El Dsouki, Youssef and Condello, Ignazio and Gunertem, Orhan Eren and Yildirim, Abducelil and Gunaydin, Serdar and Lorusso, Roberto},
title = {Optimizing Heparin and Protamine Dosing During Cardiopulmonary Bypass Using Activated Clotting Time-Guided Protocols: A Single-Centre Prospective Randomized Controlled Trial},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
doi = {10.1093/icvts/ivag197}
}
EUVIMED